KanisJA, 1994.Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report,Osteoporos Int 4 368 -81
BarcoCM,ArijaSM,PérezMR, 2012.Biochemical markers in osteoporosis: usefulness in clinical practice,Reumatol Clin 8 149 -52
NishizawaY,OhtaH,MiuraM,InabaM,IchimuraS,ShirakiM, 2013.Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis,J Bone Miner Metab 31 1 -15
LenoraJ,IvaskaK, 2010.Use of bone turnover markers in osteoporosis,Clinic Rev Bone Miner Metab 8 1 -14
IglesiasP,ArrietaF,PineraM,CarreteroB,BalsaA,ZamarronI, 2011.Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-cross laps in obese subjects with varying degrees of glucose tolerance,Clin Endocrinol 75 184 -8
BunyaratavejN,KitimanonN,BoonthitikulS., 2001.Study of the level of biochemical bone markers: NMID osteocalcin and bone resorptive marker (beta CTx) in Thai women,J Med Assoc Thai 84 S560 -5
BaigL,MansuriFA,KarimSA, 2009.Association of menopause with osteopenia and osteoporosis: results from population based study done in Karachi,J Coll Physicians Surg Pak 19 240 -4
SultanA,KhanDA,MushtaqM,HassanM., 2006.Frequency of osteoporosis and its associated risk factors in postmenopausal women in clinical practice at Rawalpindi,Pak J Pathol 17 115 -8
FatimaM,NawazH,KassiM,RehmanR,KasiPM,KassiM, 2009.Determining the risk factors and prevalence of osteoporosis using quantitative ultrasonography in Pakistani adult women,Singapore Med J 50 20 -8
ZahoorS,AyubU, 2010.Services Hospital, Peshawar, NWFP,JPMI 24 4 -8
LateefM,BaigM, 2010.Azhar A. Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females,Osteoporos Int 21 751 -5
ChopinF,BiverE,Funck-BrentanoT,BouvardB,CoiffierG,GarneroP, .Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis,Joint Bone Spine 79 26 -31
GarneroP,Sornay-RenduE,ClaustratB,DelmasPD, 2000.Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study,J Bone Miner Res 15 1526 -36
JohanssonH,OdenA,KanisJA,McCloskeyEV,MorrisHA,CooperC, 2014.A meta-analysis of reference markers of bone turnover for prediction of fracture,Calcif Tissue Int 94 560 -7
IvaskaKK,AlataloSL,HalleenJM,HellmanJ,IsakssonA, 2004.Biochemical markers of bone metabolism and prediction of fracture in elderly women,J Bone Miner Res 19 386 -93
IkiM,AkibaT,MatsumotoT,NishinoH,KagamimoriS,KagawaY, 2004.Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese population-based osteoporosis (JPOS) study,Osteoporos Int 15 981 -91
WheaterG,ElshahalyM,TuckSP,DattaHK,LaarJM, 2013.The clinical utility of bone marker measurements in osteoporosis,J Transl Med 11 201 -
BiverE,ChopinF,CoiffierG,BrentanoTF,BouvardB,GarneroP, 2012.Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis,Joint Bone Spine 79 20 -5
JunqueiraPA,da FonsecaAM,BagnoliVR,Giannella-NetotD,MangueiraCL,CoimbraCN, 2002.Comparison of bone remodelling indicators in climacteric women,Int J Fertil Womens Med 47 174 -81
BruyereO,ColletteJ,DelmasP,RouillonA,RouxC,SeidelL, 2003.Interest of biochemical markers of bone turnover for longterm prediction of new vertebral fracture in postmenopausal osteoporotic women,Maturitas 25 259 -65
ReginsterJY,HenrotinY,ChristiansenC,Gamwell-HenriksenE,Collette J, 2001.Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I,Calcif Tissue Int 69 130 -7
Majkic-SinghN,IlicM,IgnjatovicS, 2002.Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis,Clin Lab 48 407 -13
PeichlP,GriesmacherbA,MarteauR,HejcS,KumpanW,MullerMM, 2001.Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers,Clin Biochem 34 131 -9